TREMELIMUMAB
UNII QEN1X95CIX

Substance Identification & Data

This profile provides standardized clinical and technical data for Tremelimumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) QEN1X95CIX.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 745013-59-6 and the RxNorm Concept ID (RxCUI) 2619313. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

QEN1X95CIX

CAS Registry Number

745013-59-6

RxNorm Concept ID

2619313

Detailed Substance Profile

Preferred Name

TREMELIMUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

QEN1X95CIX

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C49085

National Cancer Institute reference terminology for clinical and research data.

INN ID

8716

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

RR-51

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Tremelimumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

TREMELIMUMAB

TREMELIMUMAB-ACTL

Common Names & Synonyms

IMMUNOGLOBULIN G2, ANTI-(HUMAN CTLA-4 (ANTIGEN)) (HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 HEAVY CHAIN) DISULFIDE WITH HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 LIGHT CHAIN, DIMER

IMMUNOGLOBULIN G2, ANTI-(HUMAN CTLA-4 (ANTIGEN)) (HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 HEAVY CHAIN) DISULPHIDE WITH HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 LIGHT CHAIN, DIMER

TICILIMUMAB

TREMELIMUMAB (GENETICAL RECOMBINATION)

TREMELIMUMAB (GENETICAL RECOMBINATION) [JAN]

TREMELIMUMAB [INN]

TREMELIMUMAB [JAN]

TREMELIMUMAB [USAN]

TREMELIMUMAB [WHO-DD]

TREMELIMUMAB ACTL [WHO-DD]